Back
Crescent Capital BDC 10K Form
Buy
56
CCAP
Crescent Capital BDC
Last Price:
19.13
Seasonality Move:
3.94%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CCAP News And Ratings
See the #1 stock for the next 7 days that we like better than CCAP
CCAP Financial Statistics
Sales & Book Value
| Annual Sales: | $92.46M |
|---|---|
| Cash Flow: | $-24.64M |
| Price / Cash Flow: | 9.85 |
| Annual Sales: | $20.30 |
| Price / Book: | 0.93 |
Profitability
| EPS (TTM): | 2.76000 |
|---|---|
| Net Income (TTM): | $101.87M |
| Gross Margin: | -- |
| Return on Equity: | 13.76% |
| Return on Assets: | 6.24% |
Crescent Capital BDC Earnings Forecast
Key Crescent Capital BDC Financial Ratios
- Per Share Earnings over the last 8 years have been positive in 4 years.
Crescent Capital BDC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Capital Markets |
| Sector: | Financials |
| Current Symbol: | CCAP |
| Website: | crescentbdc.com |
Debt
| Debt-to-Equity Ratio: | 1.17 |
|---|---|
| Current Ratio: | 0.9 |
| Quick Ratio: | 0.82 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.07 |
|---|---|
| Forward P/E Ratio: | 9.34 |
CCAP Technical Analysis vs Fundamental Analysis
Buy
56
Crescent Capital BDC (CCAP)
is a Buy
Is Crescent Capital BDC a Buy or a Sell?
-
Crescent Capital BDC stock is rated a Buy
The current Crescent Capital BDC [CCAP] share price is $18.78. The Score for CCAP is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.